BMGL Basel Medical Group: Price-to-Projected Revenue Ratio
Basel Medical Group is expanding its Asian presence through laboratory partnerships, which impacts the expected P/S ratio. A steady patient flow guarantees predictable revenue, while the clinic network in Hong Kong ensures business maturity. Meanwhile, 0.60 becomes the new metric value, capturing the real-time market valuation of the company's future revenue on the chart.
BMGL (baselmedical.com): analytical breakdowns and indicator data
- current price and projected stock value:
- company stock capitalization data:
- book value of equity indicators:
- business debt structure and liquidity details:
- net income and valuation multiples indicators:
BMGL - Net Profit|Expected Profit Basel Medical Group|BMGL - Price to Earnings Ratio|Projected Price to Earnings Basel Medical Group Ltd|BMGL - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple BMGL|BMGL - Operating profit before depreciation charges|Earnings per share for the last twelve months Basel Medical Group|BMGL - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months baselmedical.com|BMGL - Earnings per share growth rate in current year|Expected earnings per share growth for next year Basel Medical Group
- company sales and revenue statistics:
Fundamental company valuation:Basel Medical Group Limited BMGL
Cost optimization at Basel Medical Group (BMGL) through the outsourcing of logistics and IT infrastructure in China directly impacts future cash flow dynamics. By analyzing the forward P/S multiple, an investor assesses the ratio of current market capitalization to expected sales volume, which determines the extent of asset overvaluation and the level of market confidence in the business's scaling efficiency.
Analysis of competing companies
Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS - Price-to-Projected Revenue Ratio|SOLV: Price-to-Projected Revenue Ratio|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|Universal Health Services, Inc. - Forward Price to Sales|Price-to-Projected Revenue Ratio DaVita|Forward Price-to-Revenue Multiple RadNet Inc (RDNT)|Forward P/S Multiple OPCH|SGRY - Market Cap to Future Revenue Ratio|Forward P/S Multiple PINC (Premier, Inc.)|EYE: Market Cap to Projected Revenue|Progyny - Forward P/S Multiple|Market Cap to Expected Sales Ratio Ardent Health ARDT|SEM: Forward P/S Multiple|Forward Price-to-Revenue Multiple Astrana Corp|MD (Pediatrix Corp) - Forward P/S Multiple|Forward P/S Multiple US Physical Therapy Inc|Price-to-Projected Revenue Ratio The Pennant Group (PNTG)|Price-to-Projected Revenue Ratio ORGO (Organogenesis Holdings Inc.)|Nutex Health Corp - Forward Price-to-Revenue Multiple|Forward Price to Sales AUNA|SBC Medical Corp - Forward P/S Multiple|Projected Price to Revenue evolus.com (EOLS)|Community Health Systems, Inc. (CYH) - Price-to-Projected Revenue Ratio|BeautyHealth - Forward Price to Sales|Price-to-Projected Revenue Ratio MediWound Ltd|Market Cap to Future Revenue Ratio Biote Corporation BTMD|Forward Price-to-Revenue Multiple JYNT (The Joint Corp.)|Forward P/S Multiple docgo.com (DCGO)|Price-to-Projected Revenue Ratio P3 Health Partners PIII|GANX (Gain Therapeutics Inc.) - Future Price to Revenue|EUDA Health - Forward P/S Multiple|CLGN: Price-to-Projected Revenue Ratio|Cuprina Holdings (Cayman) Ltd (CUPR) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple concordmedical.com|AMS (American Shared Hospital Services) - Forward P/S Multiple|MRM - Projected Price to Revenue|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|Price-to-Projected Revenue Ratio DHAI (DIH Group)|Longevity Health Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio NIVF (newgenivf.com)|ATIP - Price-to-Projected Revenue Ratio|Forward Price to Sales CMAX (CareMax Inc.)|KDLY: Forward P/S Multiple|Market Cap to Future Revenue Ratio ModivCare Corp (MODV)|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Forward P/S Multiple SunLink Health Systems, Inc|Forward Price-to-Revenue Multiple BACK (IMAC Holdings)
